Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 6/20 | 0.42 |
| ▸ | PLG | P00747 | 3/20 | 0.42 |
| ▸ | F10 | P00742 | 2/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.42 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.41 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.41 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6429000 | 0.85 | MEN1 (0.53) | F2CXCR3MEN1KMT2AOPRD1 | |
| SCHEMBL29727784 | 0.84 | BDKRB2 (0.44) | F2CXCR3MEN1KMT2AOPRD1 | |
| SCHEMBL8837271 | 0.84 | OPRD1 (0.39) | F2PLGF10PRSS1EPHA2 | |
| SCHEMBL7102702 | 0.83 | F2 (0.60) | F2PLGF10PRSS1EPHA2 | |
| SCHEMBL7163251 | 0.82 | MAPK8 (0.40) | PLGMEN1KMT2AEPHA2 | |
| SCHEMBL7163247 | 0.82 | MAPK8 (0.40) | PLGMEN1KMT2AEPHA2 | |
| SCHEMBL8837269 | 0.80 | F2 (0.45) | F2PLGF10PRSS1NMUR2 | |
| SCHEMBL2038224 | 0.80 | TRHR (0.47) | F2PLGF10PRSS1 | |
| SCHEMBL8837276 | 0.79 | F2 (0.49) | F2PLGNMUR2NMUR1EPHA2 | |
| SCHEMBL7342523 | 0.78 | PLG (0.57) | F2PLGF10NMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0479489-B1 | Tripeptide antithrombotic agents | LILLY CO ELI (US) | 2003-03-19 | — | — | EP | claimed |